Company Announcements
Director/PDMR Shareholding
Related Companies
By LSE RNS
17 March 2017
RECKITT BENCKISER GROUP PLC
("RB" or the "Company")
DIRECTOR/PDMR SHAREHOLDING
Notification of transactions of Directors/Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
On 16 March 2017, Rob de Groot, Area Executive Vice President ENA, a PDMR, exercised 55,524 share options granted on 5 December 2011 at an option price of £31.20 per share and disposed of all the resulting Shares at £73.3109.
Following this transaction, Mr de Groot's shareholding is 313,675 Shares, representing 0.0448% of the Company's issued share capital. Treasury shares have not been taken into account when calculating this percentage.
The following notification is made in accordance with the requirements of the EU Market Abuse Regulation.
|
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||||||||
|
a) |
Name |
Rob de Groot |
|||||||||
|
2 |
Reason for the notification |
||||||||||
|
a) |
Position/status |
Area EVP, ENA |
|||||||||
|
b) |
Initial notification/ |
Initial notification |
|||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||
|
a) |
Name |
Reckitt Benckiser Group plc |
|||||||||
|
b) |
LEI |
5493003JFSMOJG48V108 |
|||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 10p each in Reckitt Benckiser Group plc ("Shares") GB00B24CGK77 |
|||||||||
|
b) |
Nature of the transaction |
Exercise of share options under the Reckitt Benckiser Group 2007 Long-Term Incentive Plan (the "2007 LTIP") and sale of sufficient Shares to meet Mr de Groot's resultant liabilities and disposal of balance. 1. Acquisition of Shares pursuant to exercise of options under the 2007 LTIP. 2. Disposal of Shares following share option exercise. |
|||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||
|
d) |
Aggregated information - Aggregated volume - Price |
-
- |
|||||||||
|
e) |
Date of the transaction |
2017-03-16 |
|||||||||
|
f) |
Place of the transaction |
London Stock Exchange, Main Market - XLON |
|||||||||
For further Information:
Christine Logan
Deputy Company Secretary
Tel +44 (0) 1753 217 800
About RB:
RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately 37,000 people worldwide.
Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.
RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea.
For more information visit www.rb.com
*RB is the trading name of the Reckitt Benckiser group of companies
This information is provided by RNS
You are here: news > regulatory news
10 Lower Thames St,
London EC3R 6EN